• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过MG-63成骨细胞培养和骨生成标志物基因表达评估聚羟基丁酸酯-壳聚糖/纤维素纳米晶体支架在骨组织工程中的适用性。

Evaluation of PHB-chitosan/CNC scaffolds' applicability for bone tissue engineering via MG-63 osteoblastic cell cultivation and osteogenic markers gene expression.

作者信息

Mohammadalipour Mohammad, Alihosseini Farzaneh, Toloue Elahe Bahremandi, Karbasi Saeed, Mohammadalipour Zahra

机构信息

Department of Polymer Engineering, Hakim Sabzevari University, Sabzevar 96179-76487, Iran; Department of Textile Engineering, Isfahan University of Technology, Isfahan 84156-83111, Iran.

Department of Textile Engineering, Isfahan University of Technology, Isfahan 84156-83111, Iran.

出版信息

Int J Biol Macromol. 2025 Aug;320(Pt 3):146041. doi: 10.1016/j.ijbiomac.2025.146041. Epub 2025 Jul 15.

DOI:10.1016/j.ijbiomac.2025.146041
PMID:40675281
Abstract

Tissue engineering, particularly the recreation of the three-dimensional hierarchical structure of the extracellular matrix, demands advanced biomaterials. These biomaterials can be electrospun to create microporous scaffolds with tailored properties. In this study, three natural polymers were combined to develop a novel nanocomposite scaffold designed to integrate multiple desirable functionalities and to provide sufficient cellular activity while enhancing the strength required for bone tissue. Incorporating cellulose nanocrystals (CNCs) into a polyhydroxybutyrate (PHB) and chitosan matrix led to significant improvements. Specifically, scaffold diameter was reduced by 26.44 %, surface roughness increased by 10.45 %, hydrophilicity improved by 12.05 %, modulus increased by 16.49 %, tensile strength was enhanced by 33.43 %, and crystallinity was modified by 56.8 % compared to the PHB-chitosan scaffold. The addition of CNCs also slightly decreased crystal sizes and influenced the degradation behavior. This nano-additive enhanced mineralization, promoted cell growth, and increased the viability of MG-63 osteoblast cells to 91.5 %. Furthermore, scaffolds containing 3 wt% CNCs significantly upregulated the expression of osteogenic markers, including a 10.7-fold increase in osteopontin and a 4.1-fold increase in alkaline phosphatase, highlighting their promise for bone tissue engineering. These findings demonstrate that PHB-chitosan/CNC scaffolds, with improved mechanical properties, possess considerable potential for trabecular bone tissue repair and regeneration.

摘要

组织工程,尤其是细胞外基质三维层次结构的重建,需要先进的生物材料。这些生物材料可以通过静电纺丝制成具有定制特性的微孔支架。在本研究中,将三种天然聚合物结合起来,开发出一种新型纳米复合支架,旨在整合多种理想功能,并在增强骨组织所需强度的同时提供足够的细胞活性。将纤维素纳米晶体(CNCs)掺入聚羟基丁酸酯(PHB)和壳聚糖基质中带来了显著改善。具体而言,与PHB-壳聚糖支架相比,支架直径减小了26.44%,表面粗糙度增加了10.45%,亲水性提高了12.05%,模量增加了16.49%,拉伸强度提高了33.43%,结晶度改变了56.8%。CNCs的添加还略微减小了晶体尺寸并影响了降解行为。这种纳米添加剂增强了矿化作用,促进了细胞生长,并使MG-63成骨细胞的活力提高到91.5%。此外,含有3 wt% CNCs的支架显著上调了成骨标志物的表达,包括骨桥蛋白增加了10.7倍,碱性磷酸酶增加了4.1倍,突出了它们在骨组织工程中的应用前景。这些发现表明,具有改善机械性能的PHB-壳聚糖/CNC支架在小梁骨组织修复和再生方面具有巨大潜力。

相似文献

1
Evaluation of PHB-chitosan/CNC scaffolds' applicability for bone tissue engineering via MG-63 osteoblastic cell cultivation and osteogenic markers gene expression.通过MG-63成骨细胞培养和骨生成标志物基因表达评估聚羟基丁酸酯-壳聚糖/纤维素纳米晶体支架在骨组织工程中的适用性。
Int J Biol Macromol. 2025 Aug;320(Pt 3):146041. doi: 10.1016/j.ijbiomac.2025.146041. Epub 2025 Jul 15.
2
Polyhydroxybutyrate-based osteoinductive mineralized electrospun structures that mimic components and tissue interfaces of the osteon for bone tissue engineering.基于聚羟基丁酸酯的具有骨诱导性的矿化电纺结构,模拟了骨单位的组成成分和组织界面,可用于骨组织工程。
Biofabrication. 2024 Mar 25;16(2). doi: 10.1088/1758-5090/ad331a.
3
Evaluating the osteogenic properties of polyhydroxybutyrate-zein/multiwalled carbon nanotubes (MWCNTs) electrospun composite scaffold for bone tissue engineering applications.评价聚羟基丁酸酯-玉米醇溶蛋白/多壁碳纳米管(MWCNTs)电纺复合支架用于骨组织工程应用的成骨性能。
Int J Biol Macromol. 2024 Sep;276(Pt 2):133829. doi: 10.1016/j.ijbiomac.2024.133829. Epub 2024 Jul 14.
4
Plant xylem-inspired chitosan-gelatin scaffolds reinforced with graphene oxide with a superior mechanical strength and hydrophilicity for bone tissue engineering.受植物木质部启发的氧化石墨烯增强壳聚糖-明胶支架,具有卓越的机械强度和亲水性,用于骨组织工程。
Int J Biol Macromol. 2025 Aug;319(Pt 2):145488. doi: 10.1016/j.ijbiomac.2025.145488. Epub 2025 Jun 23.
5
characterization of 3D printed polycaprolactone/graphene oxide scaffolds impregnated with alginate and gelatin hydrogels for bone tissue engineering.用于骨组织工程的负载藻酸盐和明胶水凝胶的3D打印聚己内酯/氧化石墨烯支架的表征
J Biomater Appl. 2025 Apr 25:8853282251336552. doi: 10.1177/08853282251336552.
6
Fabrication of biodegradable nanocomposite scaffolds with hydroxyapatite, magnetic clay, and graphene oxide for bone tissue engineering.用于骨组织工程的含羟基磷灰石、磁性粘土和氧化石墨烯的可生物降解纳米复合支架的制备
Sci Rep. 2025 Jul 1;15(1):22235. doi: 10.1038/s41598-025-07270-5.
7
Evaluation of Self-Assembled Nanofibrous Aggregates (SNAs) for Assessing Osteogenic Potential in the Development of Bioinks for Bone Tissue Regeneration.用于评估骨组织再生生物墨水开发中骨生成潜力的自组装纳米纤维聚集体(SNA)的评估
ACS Appl Bio Mater. 2025 Aug 18;8(8):6755-6771. doi: 10.1021/acsabm.5c00222. Epub 2025 Jul 21.
8
Mineralized osteoblast-derived exosomes and 3D-printed ceramic-based scaffolds for enhanced bone healing: A preclinical exploration.矿化成骨细胞衍生外泌体与3D打印陶瓷基支架促进骨愈合:一项临床前探索
Acta Biomater. 2025 Jun 15;200:686-702. doi: 10.1016/j.actbio.2025.05.051. Epub 2025 May 21.
9
Inorganic whiskers containing alkaline and bioactive ions enhance the comprehensive properties of 3D-printed biopolymer bone scaffold.含有碱性和生物活性离子的无机晶须增强了3D打印生物聚合物骨支架的综合性能。
Biomed Mater. 2025 Aug 12;20(5). doi: 10.1088/1748-605X/adf619.
10
Divergent effects of premineralization and prevascularization on osteogenesis and vascular integration in humanized tissue engineered bone constructs.矿化前和血管化前对人源化组织工程骨构建体中骨生成和血管整合的不同影响。
Acta Biomater. 2025 Jun 11. doi: 10.1016/j.actbio.2025.06.019.